Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders

MD Thompson, A Knaus - Genes, 2024 - mdpi.com
The case report by Mabry et al.(1970) of a family with four children with elevated tissue non-
specific alkaline phosphatase, seizures and profound developmental disability, became the …

[HTML][HTML] Inherited glycosylphosphatidylinositol deficiency: a review from molecular and clinical perspectives: A review of inherited glycosylphosphatidylinositol …

S Li, Q Tang, Y Jiang, X Chen - Acta Biochimica et Biophysica …, 2024 - pmc.ncbi.nlm.nih.gov
Glycosylphosphatidylinositol (GPI) is a highly conserved post-translational modification in
eukaryotes, which is essential for anchoring various proteins to the cell surface. Dysfunction …

AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models

Y Murakami, S Umeshita, K Imanishi… - … Therapy Methods & …, 2024 - cell.com
Thirty genes are involved in the biosynthesis and modification of
glycosylphosphatidylinositol (GPI)-anchored proteins, and defects in these genes cause …

Macrocephaly and Digital Anomalies Expand the Phenotypic Spectrum of PGAP2 Variants in Hyperphosphatasia with Impaired Intellectual Development Syndrome 3 …

S Susgun, A Ben-Mahmoud, F Rüschendorf… - Human …, 2024 - Wiley Online Library
Glycosylphosphatidylinositols (GPIs) anchor over 150 proteins as GPI‐anchored proteins
(GPI‐APs) with crucial roles in diverse biological processes. The highly conserved …

Defining the phenotype of PGAP3-congenital disorder of glycosylation; a review of 65 cases

R Altassan, MM Allers, D De Graef, R Shah… - Molecular genetics and …, 2023 - Elsevier
Biallelic pathogenic variants in PGAP3 cause a rare glycosylphosphatidyl-inositol
biogenesis disorder, PGAP3-CDG. This multisystem condition presents with a predominantly …

Innovations in Phenotyping and Diagnostics Create Opportunities for Improved Treatment and Genetic Counseling for Rare Diseases

MD Thompson - Genes, 2024 - mdpi.com
Genetic counseling and treatment options for rare developmental disabilities (DDs) have
been revolutionized by the opportunities made possible by using massively parallel …

A case report of PGAP2-related hyperphosphatasia with impaired intellectual development syndrome in a Chinese family and literature review

Y Pan, B Ren, L Chen, Q Li - Frontiers in Pediatrics, 2024 - frontiersin.org
Recently, mutations have been identified in six genes (PIGA, PIGY, PIGO, PGAP2, PIGW and
PGAP3) encoding proteins in the Glycosyl phosphatidylinositol (GPI)-anchor-synthesis …

Homozygous PGAP2 mutation cause hyperphosphatasia with mental retardation syndrome-3 (HPMRS3): Genetic and clinical evaluation of the ultra rare inherited …

A Küçükçongar Yavaş, SZ Özbey… - Molecular …, 2024 - karger.com
Introduction: Inherited glycosylphosphatidylinositol biosynthesis defect is considered a
subset of the congenital glycosylation disorder that result from mutations in the genes …

Hyperphosphatasia with Impaired Intellectual Development Syndrome in a Toddler: Diagnostic Challenges and Therapeutic Approach

PK Panda, A Palayullakandi, D Gupta… - Indian Journal of …, 2024 - Springer
To the Editor: A 2-y-old boy, first-born to consanguineous parents, presented with global
developmental delay. He could sit independently but spoke only one meaningful word. Initial …

PGAP2-Related Hyperphosphatasia-Mental Retardation Syndrome: Report of a Novel Patient, Toward a Broadening of Phenotypic Spectrum and Therapeutic …

A Saracino, M Totaro, D Politano, VDE Giorgis… - …, 2024 - thieme-connect.com
PGAP2 gene has been known to be the cause of “hyperphosphatasia, mental retardation
syndrome-3”(HPMRS3). To date, 14 pathogenic variants in PGAP2 have been identified as …